December 7, 2004

The present invention is directed to selective LXR modulators, small molecule compounds corresponding to Formula I and is further directed to a process of treating a condition in a mammal that is modulated by LXR using a therapeutically effective dose of a compound of Formula I.

60

December 7, 2004

10/327,741

December 23, 2002

549/362   549/434

C07C   323/41   (20060101)   C07C   323/42   (20060101)   C07C   323/00   (20060101)   C07D   213/32   (20060101)   C07D   213/00   (20060101)   C07D   311/00   (20060101)   C07D   317/64   (20060101)   C07D   319/00   (20060101)   C07D   317/00   (20060101)   C07D   317/56   (20060101)   C07D   319/08   (20060101)   C07D   311/16   (20060101)   C07D   409/00   (20060101)   C07D   409/12   (20060101)   C07D   333/00   (20060101)   C07D   333/38   (20060101)  

REFERENCE TO RELATED APPLICATIONS This application is a non-provisional application claiming priority from provisional application Ser. No. 60/345,163, filed Dec. 21, 2001, the entire contents of which are hereby incorporated herein by reference in its entirety.

549/434   549/362   514/469